Home
/
Journey Medical Corp
/
Financials
/
Quarterly
Journey Medical Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Journey Medical Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$17.63M
Nov 12, 2025
Q3
2025
Sep 30, 2024
$14.63M
Nov 12, 2025
Q2
2024
Jun 30, 2024
$14.86M
Aug 13, 2024
Q1
2024
Mar 31, 2024
$13.03M
May 14, 2024
Q3
2024
Sep 30, 2023
$34.54M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$17.17M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$12.21M
May 14, 2024
Q3
2023
Sep 30, 2022
$16.12M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$18.29M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$23.30M
May 22, 2023
Q3
2022
Sep 30, 2021
$19.61M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$15.29M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$10.72M
May 10, 2022
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$17.03M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$15.01M
Aug 12, 2025
Q1
2025
Mar 31, 2025
$13.14M
May 15, 2025
Q3
2025
Sep 30, 2024
$14.63M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$14.86M
Aug 12, 2025
Q1
2025
Mar 31, 2024
$13.03M
May 15, 2025
Q3
2024
Sep 30, 2023
$15.28M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$16.96M
Aug 13, 2024
Q1
2024
Mar 31, 2023
$12.17M
May 14, 2024
Q3
2023
Sep 30, 2022
$16.04M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$18.24M
Aug 10, 2023
Q1
2023
Mar 31, 2022
$20.80M
May 22, 2023
Q3
2022
Sep 30, 2021
$19.61M
Nov 10, 2022
Q2
2022
Jun 30, 2021
$15.29M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$10.72M
May 10, 2022
Q3
2021
Sep 30, 2020
$9.45M
Dec 16, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.32M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($3.80M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($4.07M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.39M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.36M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($10.44M)
May 15, 2025
Q3
2024
Sep 30, 2023
$16.79M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($8.36M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($10.14M)
May 14, 2024
Q3
2023
Sep 30, 2022
($10.08M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($7.53M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($1.38M)
May 22, 2023
Q3
2022
Sep 30, 2021
($10.65M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($11.87M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
$268.0K
May 10, 2022
Q3
2021
Sep 30, 2020
$29.0K
Dec 16, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.53M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.88M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($3.32M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.89M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($2.93M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($10.09M)
May 15, 2025
Q3
2024
Sep 30, 2023
$17.25M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($7.65M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($9.56M)
May 14, 2024
Q3
2023
Sep 30, 2022
($9.49M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($7.14M)
Aug 10, 2023
Q1
2023
Mar 31, 2022
($888.0K)
May 22, 2023
Q3
2022
Sep 30, 2021
($12.65M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($13.76M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
$585.0K
May 10, 2022
Q3
2021
Sep 30, 2020
$239.0K
Dec 16, 2021